The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Biopharma for Animal Health Market Research Report 2025
Synopsis
Highlights
The global Biopharma for Animal Health market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Biopharma for Animal Health is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Biopharma for Animal Health is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Biopharma for Animal Health include Invetx, Boehringer Ingelheim, Zoetis, Merck, CZ Vaccines, Scout Bio, Ceva, Vetoquinol and Elanco, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Biopharma for Animal Health in Prevention is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Immune Serum, which accounted for % of the global market of Biopharma for Animal Health in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharma for Animal Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma for Animal Health.
The Biopharma for Animal Health market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biopharma for Animal Health market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharma for Animal Health manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Invetx
Boehringer Ingelheim
Zoetis
Merck
CZ Vaccines
Scout Bio
Ceva
Vetoquinol
Elanco
Virbac
Product Type Insights
Global markets are presented by Biopharma for Animal Health type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Biopharma for Animal Health are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Biopharma for Animal Health segment by Type
Immune Serum
Antigen & Antibody
Vaccine (Bacteria)
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biopharma for Animal Health market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biopharma for Animal Health market.
Biopharma for Animal Health segment by Application
Prevention
Treatment
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biopharma for Animal Health market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharma for Animal Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Biopharma for Animal Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biopharma for Animal Health industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharma for Animal Health.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biopharma for Animal Health manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biopharma for Animal Health in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Highlights
The global Biopharma for Animal Health market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.
North American market for Biopharma for Animal Health is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for Biopharma for Animal Health is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
The major global manufacturers of Biopharma for Animal Health include Invetx, Boehringer Ingelheim, Zoetis, Merck, CZ Vaccines, Scout Bio, Ceva, Vetoquinol and Elanco, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.
The global market for Biopharma for Animal Health in Prevention is estimated to increase from $ million in 2022 to $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Immune Serum, which accounted for % of the global market of Biopharma for Animal Health in 2021, is expected to reach million US$ by 2028, growing at a revised CAGR of % from 2022 to 2028.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Biopharma for Animal Health, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biopharma for Animal Health.
The Biopharma for Animal Health market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Biopharma for Animal Health market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biopharma for Animal Health manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Invetx
Boehringer Ingelheim
Zoetis
Merck
CZ Vaccines
Scout Bio
Ceva
Vetoquinol
Elanco
Virbac
Product Type Insights
Global markets are presented by Biopharma for Animal Health type, along with growth forecasts through 2028. Estimates on sales and revenue are based on the price in the supply chain at which the Biopharma for Animal Health are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).
Biopharma for Animal Health segment by Type
Immune Serum
Antigen & Antibody
Vaccine (Bacteria)
Others
Application Insights
This report has provided the market size (sales and revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).
This report also outlines the market trends of each segment and consumer behaviors impacting the Biopharma for Animal Health market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Biopharma for Animal Health market.
Biopharma for Animal Health segment by Application
Prevention
Treatment
Regional Outlook
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Biopharma for Animal Health market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biopharma for Animal Health market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Biopharma for Animal Health and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Biopharma for Animal Health industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biopharma for Animal Health.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biopharma for Animal Health manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biopharma for Animal Health in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
Index1 Biopharma for Animal Health Market Overview
1.1 Product Overview and Scope of Biopharma for Animal Health
1.2 Biopharma for Animal Health Segment by Type
1.2.1 Global Biopharma for Animal Health Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Immune Serum
1.2.3 Antigen & Antibody
1.2.4 Vaccine (Bacteria)
1.2.5 Others
1.3 Biopharma for Animal Health Segment by Application
1.3.1 Global Biopharma for Animal Health Sales Comparison by Application: (2022-2028)
1.3.2 Prevention
1.3.3 Treatment
1.4 Global Biopharma for Animal Health Market Size Estimates and Forecasts
1.4.1 Global Biopharma for Animal Health Revenue 2017-2028
1.4.2 Global Biopharma for Animal Health Sales 2017-2028
1.4.3 Biopharma for Animal Health Market Size by Region: 2017 Versus 2021 Versus 2028
2 Biopharma for Animal Health Market Competition by Manufacturers
2.1 Global Biopharma for Animal Health Sales Market Share by Manufacturers (2017-2022)
2.2 Global Biopharma for Animal Health Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Biopharma for Animal Health Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Biopharma for Animal Health Manufacturing Sites, Area Served, Product Type
2.5 Biopharma for Animal Health Market Competitive Situation and Trends
2.5.1 Biopharma for Animal Health Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biopharma for Animal Health Players Market Share by Revenue
2.5.3 Global Biopharma for Animal Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Biopharma for Animal Health Retrospective Market Scenario by Region
3.1 Global Biopharma for Animal Health Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Biopharma for Animal Health Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Biopharma for Animal Health Market Facts & Figures by Country
3.3.1 North America Biopharma for Animal Health Sales by Country
3.3.2 North America Biopharma for Animal Health Revenue by Country
3.3.3 United States
3.3.4 Canada
3.4 Europe Biopharma for Animal Health Market Facts & Figures by Country
3.4.1 Europe Biopharma for Animal Health Sales by Country
3.4.2 Europe Biopharma for Animal Health Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biopharma for Animal Health Market Facts & Figures by Region
3.5.1 Asia Pacific Biopharma for Animal Health Sales by Region
3.5.2 Asia Pacific Biopharma for Animal Health Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Biopharma for Animal Health Market Facts & Figures by Country
3.6.1 Latin America Biopharma for Animal Health Sales by Country
3.6.2 Latin America Biopharma for Animal Health Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.6.6 Colombia
3.7 Middle East and Africa Biopharma for Animal Health Market Facts & Figures by Country
3.7.1 Middle East and Africa Biopharma for Animal Health Sales by Country
3.7.2 Middle East and Africa Biopharma for Animal Health Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biopharma for Animal Health Historic Market Analysis by Type
4.1 Global Biopharma for Animal Health Sales Market Share by Type (2017-2022)
4.2 Global Biopharma for Animal Health Revenue Market Share by Type (2017-2022)
4.3 Global Biopharma for Animal Health Price by Type (2017-2022)
5 Global Biopharma for Animal Health Historic Market Analysis by Application
5.1 Global Biopharma for Animal Health Sales Market Share by Application (2017-2022)
5.2 Global Biopharma for Animal Health Revenue Market Share by Application (2017-2022)
5.3 Global Biopharma for Animal Health Price by Application (2017-2022)
6 Key Companies Profiled
6.1 Invetx
6.1.1 Invetx Corporation Information
6.1.2 Invetx Description and Business Overview
6.1.3 Invetx Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.1.4 Invetx Biopharma for Animal Health Product Portfolio
6.1.5 Invetx Recent Developments/Updates
6.2 Boehringer Ingelheim
6.2.1 Boehringer Ingelheim Corporation Information
6.2.2 Boehringer Ingelheim Description and Business Overview
6.2.3 Boehringer Ingelheim Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Boehringer Ingelheim Biopharma for Animal Health Product Portfolio
6.2.5 Boehringer Ingelheim Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.3.4 Zoetis Biopharma for Animal Health Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Merck
6.4.1 Merck Corporation Information
6.4.2 Merck Description and Business Overview
6.4.3 Merck Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Merck Biopharma for Animal Health Product Portfolio
6.4.5 Merck Recent Developments/Updates
6.5 CZ Vaccines
6.5.1 CZ Vaccines Corporation Information
6.5.2 CZ Vaccines Description and Business Overview
6.5.3 CZ Vaccines Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.5.4 CZ Vaccines Biopharma for Animal Health Product Portfolio
6.5.5 CZ Vaccines Recent Developments/Updates
6.6 Scout Bio
6.6.1 Scout Bio Corporation Information
6.6.2 Scout Bio Description and Business Overview
6.6.3 Scout Bio Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Scout Bio Biopharma for Animal Health Product Portfolio
6.6.5 Scout Bio Recent Developments/Updates
6.7 Ceva
6.6.1 Ceva Corporation Information
6.6.2 Ceva Description and Business Overview
6.6.3 Ceva Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Ceva Biopharma for Animal Health Product Portfolio
6.7.5 Ceva Recent Developments/Updates
6.8 Vetoquinol
6.8.1 Vetoquinol Corporation Information
6.8.2 Vetoquinol Description and Business Overview
6.8.3 Vetoquinol Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Vetoquinol Biopharma for Animal Health Product Portfolio
6.8.5 Vetoquinol Recent Developments/Updates
6.9 Elanco
6.9.1 Elanco Corporation Information
6.9.2 Elanco Description and Business Overview
6.9.3 Elanco Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Elanco Biopharma for Animal Health Product Portfolio
6.9.5 Elanco Recent Developments/Updates
6.10 Virbac
6.10.1 Virbac Corporation Information
6.10.2 Virbac Description and Business Overview
6.10.3 Virbac Biopharma for Animal Health Sales, Revenue and Gross Margin (2017-2022)
6.10.4 Virbac Biopharma for Animal Health Product Portfolio
6.10.5 Virbac Recent Developments/Updates
7 Biopharma for Animal Health Manufacturing Cost Analysis
7.1 Biopharma for Animal Health Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biopharma for Animal Health
7.4 Biopharma for Animal Health Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biopharma for Animal Health Distributors List
8.3 Biopharma for Animal Health Customers
9 Biopharma for Animal Health Market Dynamics
9.1 Biopharma for Animal Health Industry Trends
9.2 Biopharma for Animal Health Market Drivers
9.3 Biopharma for Animal Health Market Challenges
9.4 Biopharma for Animal Health Market Restraints
10 Global Market Forecast
10.1 Biopharma for Animal Health Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biopharma for Animal Health by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Biopharma for Animal Health by Type (2023-2028)
10.2 Biopharma for Animal Health Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biopharma for Animal Health by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Biopharma for Animal Health by Application (2023-2028)
10.3 Biopharma for Animal Health Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biopharma for Animal Health by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Biopharma for Animal Health by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Biopharma for Animal Health Sales Growth Rate Comparison by Type (2022-2028) & (Units) & (US$ Million)
Table 2. Global Biopharma for Animal Health Sales Growth Rate Comparison by Application (2022-2028) & (Units) & (US$ Million)
Table 3. Global Biopharma for Animal Health Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Biopharma for Animal Health Market Competitive Situation by Manufacturers in 2021
Table 5. Global Biopharma for Animal Health Sales (Units) of Key Manufacturers (2017-2022)
Table 6. Global Biopharma for Animal Health Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Biopharma for Animal Health Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Biopharma for Animal Health Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Biopharma for Animal Health Average Price (US$/Unit) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Biopharma for Animal Health Manufacturing Sites and Area Served
Table 11. Manufacturers Biopharma for Animal Health Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biopharma for Animal Health by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biopharma for Animal Health as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biopharma for Animal Health Sales by Region (2017-2022) & (Units)
Table 16. Global Biopharma for Animal Health Sales Market Share by Region (2017-2022)
Table 17. Global Biopharma for Animal Health Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Biopharma for Animal Health Revenue Market Share by Region (2017-2022)
Table 19. North America Biopharma for Animal Health Sales by Country (2017-2022) & (Units)
Table 20. North America Biopharma for Animal Health Sales Market Share by Country (2017-2022)
Table 21. North America Biopharma for Animal Health Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Biopharma for Animal Health Revenue Market Share by Country (2017-2022)
Table 23. Europe Biopharma for Animal Health Sales by Country (2017-2022) & (Units)
Table 24. Europe Biopharma for Animal Health Sales Market Share by Country (2017-2022)
Table 25. Europe Biopharma for Animal Health Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Biopharma for Animal Health Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Biopharma for Animal Health Sales by Region (2017-2022) & (Units)
Table 28. Asia Pacific Biopharma for Animal Health Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Biopharma for Animal Health Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Biopharma for Animal Health Revenue Market Share by Region (2017-2022)
Table 31. Latin America Biopharma for Animal Health Sales by Country (2017-2022) & (Units)
Table 32. Latin America Biopharma for Animal Health Sales Market Share by Country (2017-2022)
Table 33. Latin America Biopharma for Animal Health Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Biopharma for Animal Health Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Biopharma for Animal Health Sales by Country (2017-2022) & (Units)
Table 36. Middle East and Africa Biopharma for Animal Health Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Biopharma for Animal Health Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Biopharma for Animal Health Revenue Market Share by Country (2017-2022)
Table 39. Global Biopharma for Animal Health Sales by Type (2017-2022) & (Units)
Table 40. Global Biopharma for Animal Health Sales Market Share by Type (2017-2022)
Table 41. Global Biopharma for Animal Health Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Biopharma for Animal Health Revenue Share by Type (2017-2022)
Table 43. Global Biopharma for Animal Health Price by Type (2017-2022) & (US$/Unit)
Table 44. Global Biopharma for Animal Health Sales (Units) by Application (2017-2022)
Table 45. Global Biopharma for Animal Health Sales Market Share by Application (2017-2022)
Table 46. Global Biopharma for Animal Health Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Biopharma for Animal Health Revenue Share by Application (2017-2022)
Table 48. Global Biopharma for Animal Health Price by Application (2017-2022) & (US$/Unit)
Table 49. Invetx Corporation Information
Table 50. Invetx Description and Business Overview
Table 51. Invetx Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 52. Invetx Biopharma for Animal Health Product
Table 53. Invetx Recent Developments/Updates
Table 54. Boehringer Ingelheim Corporation Information
Table 55. Boehringer Ingelheim Description and Business Overview
Table 56. Boehringer Ingelheim Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 57. Boehringer Ingelheim Biopharma for Animal Health Product
Table 58. Boehringer Ingelheim Recent Developments/Updates
Table 59. Zoetis Corporation Information
Table 60. Zoetis Description and Business Overview
Table 61. Zoetis Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 62. Zoetis Biopharma for Animal Health Product
Table 63. Zoetis Recent Developments/Updates
Table 64. Merck Corporation Information
Table 65. Merck Description and Business Overview
Table 66. Merck Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 67. Merck Biopharma for Animal Health Product
Table 68. Merck Recent Developments/Updates
Table 69. CZ Vaccines Corporation Information
Table 70. CZ Vaccines Description and Business Overview
Table 71. CZ Vaccines Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 72. CZ Vaccines Biopharma for Animal Health Product
Table 73. CZ Vaccines Recent Developments/Updates
Table 74. Scout Bio Corporation Information
Table 75. Scout Bio Description and Business Overview
Table 76. Scout Bio Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 77. Scout Bio Biopharma for Animal Health Product
Table 78. Scout Bio Recent Developments/Updates
Table 79. Ceva Corporation Information
Table 80. Ceva Description and Business Overview
Table 81. Ceva Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 82. Ceva Biopharma for Animal Health Product
Table 83. Ceva Recent Developments/Updates
Table 84. Vetoquinol Corporation Information
Table 85. Vetoquinol Description and Business Overview
Table 86. Vetoquinol Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 87. Vetoquinol Biopharma for Animal Health Product
Table 88. Vetoquinol Recent Developments/Updates
Table 89. Elanco Corporation Information
Table 90. Elanco Description and Business Overview
Table 91. Elanco Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 92. Elanco Biopharma for Animal Health Product
Table 93. Elanco Recent Developments/Updates
Table 94. Virbac Corporation Information
Table 95. Virbac Description and Business Overview
Table 96. Virbac Biopharma for Animal Health Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 97. Virbac Biopharma for Animal Health Product
Table 98. Virbac Recent Developments/Updates
Table 99. Production Base and Market Concentration Rate of Raw Material
Table 100. Key Suppliers of Raw Materials
Table 101. Biopharma for Animal Health Distributors List
Table 102. Biopharma for Animal Health Customers List
Table 103. Biopharma for Animal Health Market Trends
Table 104. Biopharma for Animal Health Market Drivers
Table 105. Biopharma for Animal Health Market Challenges
Table 106. Biopharma for Animal Health Market Restraints
Table 107. Global Biopharma for Animal Health Sales Forecast by Type (2023-2028) & (Units)
Table 108. Global Biopharma for Animal Health Sales Market Share Forecast by Type (2023-2028)
Table 109. Global Biopharma for Animal Health Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 110. Global Biopharma for Animal Health Revenue Market Share Forecast by Type (2023-2028)
Table 111. Global Biopharma for Animal Health Sales Forecast by Application (2023-2028) & (Units)
Table 112. Global Biopharma for Animal Health Sales Market Share Forecast by Application (2023-2028)
Table 113. Global Biopharma for Animal Health Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 114. Global Biopharma for Animal Health Revenue Market Share Forecast by Application (2023-2028)
Table 115. Global Biopharma for Animal Health Sales Forecast by Region (2023-2028) & (Units)
Table 116. Global Biopharma for Animal Health Sales Market Share Forecast by Region (2023-2028)
Table 117. Global Biopharma for Animal Health Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 118. Global Biopharma for Animal Health Revenue Market Share Forecast by Region (2023-2028)
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biopharma for Animal Health
Figure 2. Global Biopharma for Animal Health Market Share by Type in 2021 & 2028
Figure 3. Immune Serum Product Picture
Figure 4. Antigen & Antibody Product Picture
Figure 5. Vaccine (Bacteria) Product Picture
Figure 6. Others Product Picture
Figure 7. Global Biopharma for Animal Health Market Share by Application in 2021 & 2028
Figure 8. Prevention
Figure 9. Treatment
Figure 10. Global Biopharma for Animal Health Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Biopharma for Animal Health Market Size (2017-2028) & (US$ Million)
Figure 12. Global Biopharma for Animal Health Sales (2017-2028) & (Units)
Figure 13. Biopharma for Animal Health Sales Share by Manufacturers in 2021
Figure 14. Global Biopharma for Animal Health Revenue Share by Manufacturers in 2021
Figure 15. The Global 5 and 10 Largest Biopharma for Animal Health Players: Market Share by Revenue in 2021
Figure 16. Biopharma for Animal Health Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 17. Global Biopharma for Animal Health Sales Market Share by Region (2017-2022)
Figure 18. Global Biopharma for Animal Health Sales Market Share by Region in 2021
Figure 19. Global Biopharma for Animal Health Revenue Market Share by Region (2017-2022)
Figure 20. Global Biopharma for Animal Health Revenue Market Share by Region in 2021
Figure 21. United States Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Canada Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. Germany Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. France Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. U.K. Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Italy Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. Russia Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. China Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. Japan Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. South Korea Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. India Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. Australia Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. China Taiwan Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Indonesia Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Thailand Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Malaysia Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Mexico Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Brazil Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Argentina Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Colombia Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. Turkey Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Saudi Arabia Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 43. UAE Biopharma for Animal Health Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 44. Sales Market Share of Biopharma for Animal Health by Type (2017-2022)
Figure 45. Manufacturing Cost Structure of Biopharma for Animal Health
Figure 46. Manufacturing Process Analysis of Biopharma for Animal Health
Figure 47. Biopharma for Animal Health Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
